Transmission Histories: Traversing missing links in the spread of HIV

Combining clinical and genetic data can improve the effectiveness of virus tracking with the aim of reducing the number of HIV cases by 2030.
  • Download
  • Cite
  • CommentOpen annotations (there are currently 0 annotations on this page).
  1. Erin Brintnell
  2. Art Poon  Is a corresponding author
  1. Department of Pathology and Laboratory Medicine, Western University, Canada
  2. Department of Computer Science, Western University, Canada

The human immunodeficiency virus type 1 (HIV-1), which can lead to acquired immune deficiency syndrome (AIDS), remains a leading cause of death and a health threat worldwide, with over 38.4 million people currently living with the virus. Global health sector strategies strive to end HIV-1 epidemics by 2030 (Duncombe et al., 2019). This requires significant investment in resources to treat and prevent the disease, such as reducing the number of people who do not know they are carrying the virus and improving the availability and affordability of effective treatments.

In cities that have scaled up HIV-1 treatment and prevention, it will be crucial to establish whether new HIV-1 infections are due to ongoing local transmission or to infections acquired abroad. This means reconstructing the spread of HIV-1 between individuals through contact tracing: interviewing people recently diagnosed with HIV, and locating and notifying their intimate partners. However, contact tracing is both time-consuming and intrusive (El-Sadr et al., 2022).

A cost-effective alternative to contact tracing is to compare the genomic sequences of HIV-1 samples from different patients, which are often collected to screen for mutations that confer drug resistance. Infections that are genetically similar are more likely to be related through recent transmissions. This is especially true for HIV-1, a rapidly evolving virus that becomes genetically unique within months of an infection (Williamson, 2003).

These genetic sequences can be used to build a tree that represents the shared evolutionary history of the infections and approximates the history of recent transmissions (De Maio et al., 2018; Romero-Severson et al., 2014). Furthermore, the spread of infections from one place to another can be extrapolated by reconstructing locations of ‘ancestral’ infections at deeper nodes of the tree from the known locations at the tips (Faria et al., 2011). The accuracy of these estimates, however, is impeded by the unknown number of people with undiagnosed infections, or with diagnosed infections that have not been sequenced (Didelot et al., 2017). In addition, reconstructing transmission patterns from HIV-1 sequences comes with its own ethical challenges because HIV-1 transmission is criminalized in many countries (Dawson et al., 2020).

Now, in eLife, Oliver Ratmann at the HIV Transmission Elimination Amsterdam Consortium and colleagues – including Alexandra Blenkinsop as first author – report an innovative approach to overcome the disadvantages of sequence analysis (Blenkinsop et al., 2022). Blenkinsop et al. combined different data sources to reconstruct the transmission histories of HIV-1 in Amsterdam, which has the highest concentration of HIV-1 cases in the Netherlands. Amsterdam is also part of the Fast-Track city network, which provides funds to expand effective HIV prevention, testing and treatment services.

Blenkinsop et al. extended the standard approach of reconstructing transmission histories from HIV-1 sequences by incorporating additional information from clinical biomarkers (biological indicators of disease progression or response to treatment) and other patient data (Figure 1). A statistical model was fitted to two biomarkers: the number of HIV-1 particles circulating in the blood (the viral load) and the number of white blood cells targeted by HIV-1. Based on how these biomarkers changed over time, it was possible to estimate the length of time between a person’s HIV-1 infection and diagnosis. These estimates were then used to infer how many cases were transmitted from people with unsequenced infections, adjusting for factors like route of transmission (e.g., injection drug use), age group, and place of birth.

Estimating the number of unsampled HIV-1 infections.

The top panel illustrates how a chain of HIV-1 infections may be partially sampled over time. The top dashed line shows an infection (represented by the virus particle symbol) that is transmitted …

Despite extensive measures to curb the transmission of HIV in Amsterdam, results from Blenkinsop et al. suggest that many HIV-1 infections have remained undiagnosed for a long time, especially among heterosexual residents and recent arrivals from sub-Saharan Africa. Further, they provide evidence of ongoing HIV-1 transmission within the city over the duration of the five-year study. These results suggest that, while Amsterdam has made significant progress in reducing the spread of HIV-1, closing the final gap to end the local epidemic by 2030 remains a challenge.

The study also highlights the importance of linking HIV-1 sequences to both clinical and demographic information to determine which groups have been neglected by the generalized scale-up of public health testing and treatment. This may also be a critical step for other cities in the FastTrack initiative. Furthermore, the work of Blenkinsop et al. mirrors ongoing challenges in tracking and controlling other infectious diseases like COVID-19, which is characterised by an abundance of viral genome sequences but a lack of linked contextual information, including clinical outcomes, travel histories and sampling strategies (Chiara et al., 2021; Chen et al., 2022).

References

Article and author information

Author details

  1. Erin Brintnell

    Erin Brintnell is in the Department of Pathology and Laboratory Medicine, Western University, London, Canada

    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5042-7799
  2. Art Poon

    Art Poon in the Department of Pathology and Laboratory Medicine, the Department of Microbiology and Immunology, and the Department of Computer Science, Western University, London, Canada

    For correspondence
    apoon42@uwo.ca
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3779-154X

Publication history

  1. Version of Record published:

Copyright

© 2022, Brintnell and Poon

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 302
    views
  • 42
    downloads
  • 0
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

Further reading

    1. Epidemiology and Global Health
    Marina Padilha, Victor Nahuel Keller ... Gilberto Kac
    Research Article

    Background: The role of circulating metabolites on child development is understudied. We investigated associations between children's serum metabolome and early childhood development (ECD).

    Methods: Untargeted metabolomics was performed on serum samples of 5,004 children aged 6-59 months, a subset of participants from the Brazilian National Survey on Child Nutrition (ENANI-2019). ECD was assessed using the Survey of Well-being of Young Children's milestones questionnaire. The graded response model was used to estimate developmental age. Developmental quotient (DQ) was calculated as the developmental age divided by chronological age. Partial least square regression selected metabolites with a variable importance projection ≥ 1. The interaction between significant metabolites and the child's age was tested.

    Results: Twenty-eight top-ranked metabolites were included in linear regression models adjusted for the child's nutritional status, diet quality, and infant age. Cresol sulfate (β = -0.07; adjusted-p < 0.001), hippuric acid (β = -0.06; adjusted-p < 0.001), phenylacetylglutamine (β = -0.06; adjusted-p < 0.001), and trimethylamine-N-oxide (β = -0.05; adjusted-p = 0.002) showed inverse associations with DQ. We observed opposite directions in the association of DQ for creatinine (for children aged -1 SD: β = -0.05; p =0.01; +1 SD: β = 0.05; p =0.02) and methylhistidine (-1 SD: β = - 0.04; p =0.04; +1 SD: β = 0.04; p =0.03).

    Conclusion: Serum biomarkers, including dietary and microbial-derived metabolites involved in the gut-brain axis, may potentially be used to track children at risk for developmental delays.

    Funding: Supported by the Brazilian Ministry of Health and the Brazilian National Research Council.

    1. Epidemiology and Global Health
    Riccardo Spott, Mathias W Pletz ... Christian Brandt
    Research Article

    Given the rapid cross-country spread of SARS-CoV-2 and the resulting difficulty in tracking lineage spread, we investigated the potential of combining mobile service data and fine-granular metadata (such as postal codes and genomic data) to advance integrated genomic surveillance of the pandemic in the federal state of Thuringia, Germany. We sequenced over 6500 SARS-CoV-2 Alpha genomes (B.1.1.7) across 7 months within Thuringia while collecting patients’ isolation dates and postal codes. Our dataset is complemented by over 66,000 publicly available German Alpha genomes and mobile service data for Thuringia. We identified the existence and spread of nine persistent mutation variants within the Alpha lineage, seven of which formed separate phylogenetic clusters with different spreading patterns in Thuringia. The remaining two are subclusters. Mobile service data can indicate these clusters’ spread and highlight a potential sampling bias, especially of low-prevalence variants. Thereby, mobile service data can be used either retrospectively to assess surveillance coverage and efficiency from already collected data or to actively guide part of a surveillance sampling process to districts where these variants are expected to emerge. The latter concept was successfully implemented as a proof-of-concept for a mobility-guided sampling strategy in response to the surveillance of Omicron sublineage BQ.1.1. The combination of mobile service data and SARS-CoV-2 surveillance by genome sequencing is a valuable tool for more targeted and responsive surveillance.